Get our Free Drug Patent Expiration Updates

Serving hundreds of leading biopharmaceutical companies globally:

Deloitte
AstraZeneca
Farmers Insurance
Cantor Fitzgerald
Boehringer Ingelheim
Daiichi Sankyo
Teva
Julphar
Johnson and Johnson

Generated: September 18, 2018

DrugPatentWatch Database Preview

Hospira Inc Company Profile

« Back to Dashboard

What is the competitive landscape for HOSPIRA INC, and what generic and branded alternatives to HOSPIRA INC drugs are available?

HOSPIRA INC has eighty-four approved drugs.

There are four tentative approvals on HOSPIRA INC drugs.

Summary for Hospira Inc

Drugs and US Patents for Hospira Inc

Applicant Tradename Generic Name Dosage NDA Approval Date TE Type RLD RS Patent No. Patent Expiration Product Substance Delist Req. Exclusivity Expiration
Hospira Inc BUSULFAN busulfan INJECTABLE;INJECTION 205672-001 Jul 31, 2018 AP RX No No ➤ Try a Free Trial ➤ Try a Free Trial
Hospira Inc CEFUROXIME SODIUM cefuroxime sodium INJECTABLE;INTRAMUSCULAR, INTRAVENOUS 065483-001 Oct 15, 2008 AP RX No No ➤ Try a Free Trial ➤ Try a Free Trial
Hospira Inc AMINOSYN II 4.25% W/ ELECT AND ADJUSTED PHOSPHATE IN DEXTROSE 10% IN PLASTIC CONTAINER amino acids; dextrose; magnesium chloride; potassium acetate; potassium chloride; potassium phosphate, dibasic; sodium chloride INJECTABLE;INJECTION 019682-003 Nov 1, 1988 DISCN No No ➤ Try a Free Trial ➤ Try a Free Trial
Hospira Inc AMPICILLIN SODIUM ampicillin sodium INJECTABLE;INJECTION 202864-003 Sep 4, 2015 AP RX No No ➤ Try a Free Trial ➤ Try a Free Trial
Hospira Inc MAXIPIME cefepime hydrochloride INJECTABLE;INJECTION 050679-003 Jan 18, 1996 AP RX Yes Yes ➤ Try a Free Trial ➤ Try a Free Trial
Hospira Inc VEINAMINE 8% amino acids; magnesium chloride; potassium acetate; potassium chloride; sodium acetate INJECTABLE;INJECTION 017957-001 Approved Prior to Jan 1, 1982 DISCN No No ➤ Try a Free Trial ➤ Try a Free Trial
Hospira Inc CEFOTAXIME SODIUM cefotaxime sodium INJECTABLE;INJECTION 065290-003 Aug 11, 2006 AP RX No No ➤ Try a Free Trial ➤ Try a Free Trial
Applicant Tradename Generic Name Dosage NDA Approval Date TE Type RLD RS Patent No. Patent Expiration Product Substance Delist Req. Exclusivity Expiration

This preview shows a limited data set.
Subscribe to access the full database, or try a Free Trial

Paragraph IV (Patent) Challenges for HOSPIRA INC drugs
Drugname Dosage Strength Tradename Submissiondate
➤ Subscribe Injection 1 mg/mL, 50 mL vials ➤ Subscribe 2011-12-16
➤ Subscribe Injection 100 mg/mL, 2.5 mL vials ➤ Subscribe 2007-09-24
Similar Applicant Names
Applicants may be listed under multiple names.
Here is a list of applicants with similar names.

For more information try a trial or see the plans and pricing

Serving hundreds of leading biopharmaceutical companies globally:

Deloitte
Dow
Fish and Richardson
Medtronic
McKesson
US Department of Justice
QuintilesIMS
Citi
UBS

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verifification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.